| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash | 59,273 | 210,582 | ||
| Accounts receivable | 59 | 59 | ||
| Inventory | 44,228 | 39,574 | ||
| Security deposit | 2,500 | 2,500 | ||
| Prepaid expense | 0 | 0 | ||
| Other receivable | 2,800 | 2,800 | ||
| Total current assets | 108,860 | 255,515 | ||
| Property and equipment, net | 15,500 | 17,000 | ||
| Total assets | 124,360 | 272,515 | ||
| Accounts payable and accrued liabilities | 230,768 | 204,081 | ||
| Derivative liabilities | 967,406 | 860,636 | ||
| Convertible notes | 359,300 | 311,000 | ||
| Notes payable | 32,096 | 32,096 | ||
| Stock payable | 0 | - | ||
| Total current liabilities | 1,589,570 | 1,407,813 | ||
| Total liabilities | 1,589,570 | 1,407,813 | ||
| Preferred stock, value-Series APreferred Stock | 1 | 1 | ||
| Preferred stock, value-Series BPreferred Stock | 1 | 1 | ||
| Preferred stock, value-Series CPreferred Stock | 100 | 100 | ||
| Preferred stock, value-Series DPreferred Stock | 16 | 13 | ||
| Common stock (.0001 par value, 1,250,000,000 shares authorized 10,938,725 and 8,215,426 shares issued and outstanding as of september 30, 2025 and december 31, 2024, and 66 issuable, respectively) | 1,093 | 994 | ||
| Additional paid-in capital | 8,437,322 | 8,387,834 | ||
| Subscription receivable | 5,885 | 5,885 | ||
| Accumulated deficit | -9,897,858 | -9,518,356 | ||
| Total stockholders' deficit | -1,465,210 | -1,135,298 | ||
| Total liabilities and stockholders' deficit | 124,360 | 272,515 | ||
BIOADAPTIVES, INC. (BDPT)
BIOADAPTIVES, INC. (BDPT)